Navigation and service

You are here:Homepage

Paul-Ehrlich-Institut (PEI)

The Paul-Ehrlich-Institut, the Federal Institute for Vaccines and Biomedicines, makes an essential contribution to the availability and safety of effective biomedical products. In addition to the granting of marketing authorisations, the regulatory responsibilities of the institute include: providing scientific advice on the development of medicinal products, approving clinical trials, experimental product testing and the official testing and release of batches as well as the assessment of adverse reactions to medicinal products.